Christopher Y. Chai, Chief Financial Officer at Principia Biopharma Inc. (PRNB), sold 12,424 shares at $65.94 ($818K) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Open-market sale of $818k PRNB by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.86 | 2,684 | $171K | 20.9% |
| 2 | $63.86 | 2,684 | $171K | 20.9% |
| 3 | $64.91 | 545 | $35K | 4.3% |
| 4 | $65.94 | 1,350 | $89K | 10.9% |
| 5 | $67.08 | 605 | $41K | 5.0% |
| 6 | $68.13 | 2,240 |
| $153K |
| 18.7% |
| 7 | $68.13 | 2,240 | $153K | 18.7% |
| 8 | $68.52 | 76 | $5K | 0.6% |
| Total | $65.86 avg | 12,424 | $818K | 100% |
| Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-09-22 | $225K | — | Filing → |
| MAPP | SELL | 2010-07-22 | $203K | — | Filing → |